Literature DB >> 4395742

Comparative chronotropic activity of beta-adrenoceptive antagonists.

A M Barrett, J Carter.   

Abstract

1. Chronotropic dose-response curves (non-cumulative) for beta-adrenoceptive antagonists were constructed from results in rats anaesthetized with pentobarbitone and depleted of catecholamines by pre-treatment with syrosingopine.2. Depletion of catecholamines lowered resting heart rate and reduced the threshold to the chronotropic action of isoprenaline by about 50%. Eight beta-adrenoceptive antagonists produced a dose-dependent chronotropic response but the maximum response was in all cases smaller than that obtained with isoprenaline. The order of activity was dichloroisoprenaline>LB 46>practolol>INPEA>oxprenolol>pronethalol>alprenolol>I.C.I. 45,763 (Kö 592). Propranolol and sotalol were without significant activity. The duration of the chronotropic response to the antagonists was more prolonged than that to isoprenaline. Propranolol caused a parallel shift to the right of the dose-response curves for the agonist effects of the antagonists.3. Estimation of beta-adrenoceptor blocking activity in anaesthetized cats gave an order of activity dissimilar to that found for maximum agonist responses: LB 46 > oxprenolol > alprenolol > propranolol > I.C.I. 45,763 > practolol > dichloroisoprenaline > sotalol > INPEA > pronethalol.4. Consideration of chemical structure and physico-chemical properties did not explain the differences between the agonist activities of the adrenoceptive antagonists.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4395742      PMCID: PMC1703170          DOI: 10.1111/j.1476-5381.1970.tb10619.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  18 in total

1.  Cardio-selective beta-blockade.

Authors:  A M Barrett; A F Crowther; D Dunlop; R G Shanks; L H Smith
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

2.  Some pharmacological properties of a new adrenergic beta-receptor antagonist.

Authors:  R G Shanks; T M Wood; A C Dornhorst; M L Clark
Journal:  Nature       Date:  1966-10-01       Impact factor: 49.962

3.  Inotropic and chronotropic effects of a series of beta-adrenergic blocking drugs: some structure-activity relationships.

Authors:  J V Levy; V Richards
Journal:  Proc Soc Exp Biol Med       Date:  1966-06

4.  Evaluation of the cardiac effects of several beta adrenergic blocking agents.

Authors:  J R Blinks
Journal:  Ann N Y Acad Sci       Date:  1967-02-10       Impact factor: 5.691

Review 5.  The pharmacology of beta-adrenergic blocking agents.

Authors:  B R Lucchesi; L S Whitsitt
Journal:  Prog Cardiovasc Dis       Date:  1969-03       Impact factor: 8.194

6.  [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].

Authors:  H Brunner; P R Hedwall; M Meier
Journal:  Arzneimittelforschung       Date:  1968-02

7.  Hemodynamic effects of propranolol and H 56/28 in man. A comparative study of two beta-adrenergic receptor antagonists.

Authors:  S A Forsberg; G Johnsson
Journal:  Life Sci       Date:  1967-06-01       Impact factor: 5.037

8.  Pharmacological properties of H 56-28--a beta-adrenergic receptor antagonist.

Authors:  B Ablad; M Brogård; L Ek
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1967

9.  A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.

Authors:  J G Papp; E M Williams
Journal:  Br J Pharmacol       Date:  1969-10       Impact factor: 8.739

10.  The effects of some beta-adrenoreceptor blocking drugs on the uptake and release of noradrenaline by the heart.

Authors:  J W Foo; A Jowett; A Stafford
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739

View more
  52 in total

1.  Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.

Authors:  M Rand; M Law; D F Story; M W McCulloch
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Responses of the cardiovascular system of the rat to noradrenaline infusions and their modification by adrenoceptor blocking agents.

Authors:  F J Imms; R L Neame; D A Powis
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

3.  Beta-Adrenoceptor studies. 4. Influence of albumin on in vitro beta-adrenoceptor blocking and antiarrhythmic properties of propranolol, pindolol, practolol and metoprolol.

Authors:  J Zaagsma; L Meems; M Boorsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

4.  An analysis of skin prick test reactions in 656 asthmatic patients.

Authors:  D J Hendrick; R J Davies; M F D'Souza; J Pepys
Journal:  Thorax       Date:  1975-02       Impact factor: 9.139

5.  Some effects of Kö 1313 in animals and man.

Authors:  J M Ekue; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

6.  The subdivision of beta-adrenoceptors in the cardiovascular system of the rat.

Authors:  F J Imms; R L Neame; D A Powis
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

7.  Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.

Authors:  J M Rapola; T J Pellinen; P Koskinen; L Toivonen; M S Nieminen
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 8.  Pindolol--the pharmacology of a partial agonist.

Authors:  B J Clark; K Menninger; A Bertholet
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

9.  Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.

Authors:  P C O'Connor; M J Finch; D W Harron; P A Meredith; D G McDevitt; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

10.  Effects of propranolol and oxprenolol on the vasoconstrictor response to noradrenaline in the superficial hand vein in man.

Authors:  J O'Grady; V Oh; P Turner
Journal:  Eur J Clin Pharmacol       Date:  1978-11-16       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.